Global Alprostadil Injection Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
A prostaglandin
The global market for Alprostadil Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Alprostadil Injection players cover Louston, CP Group, Yinglian Biopharmaceutical, Green Biology and HPGC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Alprostadil Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Alprostadil Injection market, with both quantitative and qualitative data, to help readers understand how the Alprostadil Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Vial.
Market Segmentation:
The study segments the Alprostadil Injection market and forecasts the market size by Dosage Strength (0.5Mg/Ml, 1Mg/Ml and 2Mg/Ml), by Application (Myocardial Infarction, Thrombotic Vasculitis, Occlusive Arteriosclerosis and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
Chapter 1: Scope of Alprostadil Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Alprostadil Injection market size (sales and revenue) and CAGR, Alprostadil Injection market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Alprostadil Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Alprostadil Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Alprostadil Injection market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Louston, CP Group, Yinglian Biopharmaceutical, Green Biology, HPGC, Swiss Parenterals, Endo Pharm, Ferring Pharmaceuticals and Hikma Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
A prostaglandin
The global market for Alprostadil Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Alprostadil Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Alprostadil Injection players cover Louston, CP Group, Yinglian Biopharmaceutical, Green Biology and HPGC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Alprostadil Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Alprostadil Injection market, with both quantitative and qualitative data, to help readers understand how the Alprostadil Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Vial.
Market Segmentation:
The study segments the Alprostadil Injection market and forecasts the market size by Dosage Strength (0.5Mg/Ml, 1Mg/Ml and 2Mg/Ml), by Application (Myocardial Infarction, Thrombotic Vasculitis, Occlusive Arteriosclerosis and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
- 0.5Mg/Ml
- 1Mg/Ml
- 2Mg/Ml
- Other
- Myocardial Infarction
- Thrombotic Vasculitis
- Occlusive Arteriosclerosis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Louston
- CP Group
- Yinglian Biopharmaceutical
- Green Biology
- HPGC
- Swiss Parenterals
- Endo Pharm
- Ferring Pharmaceuticals
- Hikma Pharmaceuticals
- Lifespan Biotech
- Viatris
- Orifarm Group
- Pfizer
- Sandoz
- Teva Pharmaceutical
Chapter 1: Scope of Alprostadil Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Alprostadil Injection market size (sales and revenue) and CAGR, Alprostadil Injection market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Alprostadil Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Alprostadil Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Alprostadil Injection market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Louston, CP Group, Yinglian Biopharmaceutical, Green Biology, HPGC, Swiss Parenterals, Endo Pharm, Ferring Pharmaceuticals and Hikma Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alprostadil Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alprostadil Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alprostadil Injection by Country/Region, 2017, 2022 & 2028
2.2 Alprostadil Injection Segment by Dosage Strength
2.2.1 0.5Mg/Ml
2.2.2 1Mg/Ml
2.2.3 2Mg/Ml
2.2.4 Other
2.3 Alprostadil Injection Sales by Dosage Strength
2.3.1 Global Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Alprostadil Injection Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Alprostadil Injection Sale Price by Dosage Strength (2017-2022)
2.4 Alprostadil Injection Segment by Application
2.4.1 Myocardial Infarction
2.4.2 Thrombotic Vasculitis
2.4.3 Occlusive Arteriosclerosis
2.4.4 Other
2.5 Alprostadil Injection Sales by Application
2.5.1 Global Alprostadil Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Alprostadil Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alprostadil Injection Sale Price by Application (2017-2022)
3 GLOBAL ALPROSTADIL INJECTION BY COMPANY
3.1 Global Alprostadil Injection Breakdown Data by Company
3.1.1 Global Alprostadil Injection Annual Sales by Company (2020-2022)
3.1.2 Global Alprostadil Injection Sales Market Share by Company (2020-2022)
3.2 Global Alprostadil Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Alprostadil Injection Revenue by Company (2020-2022)
3.2.2 Global Alprostadil Injection Revenue Market Share by Company (2020-2022)
3.3 Global Alprostadil Injection Sale Price by Company
3.4 Key Manufacturers Alprostadil Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alprostadil Injection Product Location Distribution
3.4.2 Players Alprostadil Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALPROSTADIL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Alprostadil Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Alprostadil Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alprostadil Injection Annual Revenue by Geographic Region
4.2 World Historic Alprostadil Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Alprostadil Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alprostadil Injection Annual Revenue by Country/Region
4.3 Americas Alprostadil Injection Sales Growth
4.4 APAC Alprostadil Injection Sales Growth
4.5 Europe Alprostadil Injection Sales Growth
4.6 Middle East & Africa Alprostadil Injection Sales Growth
5 AMERICAS
5.1 Americas Alprostadil Injection Sales by Country
5.1.1 Americas Alprostadil Injection Sales by Country (2017-2022)
5.1.2 Americas Alprostadil Injection Revenue by Country (2017-2022)
5.2 Americas Alprostadil Injection Sales by Dosage Strength
5.3 Americas Alprostadil Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alprostadil Injection Sales by Region
6.1.1 APAC Alprostadil Injection Sales by Region (2017-2022)
6.1.2 APAC Alprostadil Injection Revenue by Region (2017-2022)
6.2 APAC Alprostadil Injection Sales by Dosage Strength
6.3 APAC Alprostadil Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alprostadil Injection by Country
7.1.1 Europe Alprostadil Injection Sales by Country (2017-2022)
7.1.2 Europe Alprostadil Injection Revenue by Country (2017-2022)
7.2 Europe Alprostadil Injection Sales by Dosage Strength
7.3 Europe Alprostadil Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alprostadil Injection by Country
8.1.1 Middle East & Africa Alprostadil Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alprostadil Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Alprostadil Injection Sales by Dosage Strength
8.3 Middle East & Africa Alprostadil Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alprostadil Injection
10.3 Manufacturing Process Analysis of Alprostadil Injection
10.4 Industry Chain Structure of Alprostadil Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alprostadil Injection Distributors
11.3 Alprostadil Injection Customer
12 WORLD FORECAST REVIEW FOR ALPROSTADIL INJECTION BY GEOGRAPHIC REGION
12.1 Global Alprostadil Injection Market Size Forecast by Region
12.1.1 Global Alprostadil Injection Forecast by Region (2023-2028)
12.1.2 Global Alprostadil Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alprostadil Injection Forecast by Dosage Strength
12.7 Global Alprostadil Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Louston
13.1.1 Louston Company Information
13.1.2 Louston Alprostadil Injection Product Offered
13.1.3 Louston Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Louston Main Business Overview
13.1.5 Louston Latest Developments
13.2 CP Group
13.2.1 CP Group Company Information
13.2.2 CP Group Alprostadil Injection Product Offered
13.2.3 CP Group Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CP Group Main Business Overview
13.2.5 CP Group Latest Developments
13.3 Yinglian Biopharmaceutical
13.3.1 Yinglian Biopharmaceutical Company Information
13.3.2 Yinglian Biopharmaceutical Alprostadil Injection Product Offered
13.3.3 Yinglian Biopharmaceutical Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Yinglian Biopharmaceutical Main Business Overview
13.3.5 Yinglian Biopharmaceutical Latest Developments
13.4 Green Biology
13.4.1 Green Biology Company Information
13.4.2 Green Biology Alprostadil Injection Product Offered
13.4.3 Green Biology Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Green Biology Main Business Overview
13.4.5 Green Biology Latest Developments
13.5 HPGC
13.5.1 HPGC Company Information
13.5.2 HPGC Alprostadil Injection Product Offered
13.5.3 HPGC Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 HPGC Main Business Overview
13.5.5 HPGC Latest Developments
13.6 Swiss Parenterals
13.6.1 Swiss Parenterals Company Information
13.6.2 Swiss Parenterals Alprostadil Injection Product Offered
13.6.3 Swiss Parenterals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Swiss Parenterals Main Business Overview
13.6.5 Swiss Parenterals Latest Developments
13.7 Endo Pharm
13.7.1 Endo Pharm Company Information
13.7.2 Endo Pharm Alprostadil Injection Product Offered
13.7.3 Endo Pharm Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Endo Pharm Main Business Overview
13.7.5 Endo Pharm Latest Developments
13.8 Ferring Pharmaceuticals
13.8.1 Ferring Pharmaceuticals Company Information
13.8.2 Ferring Pharmaceuticals Alprostadil Injection Product Offered
13.8.3 Ferring Pharmaceuticals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ferring Pharmaceuticals Main Business Overview
13.8.5 Ferring Pharmaceuticals Latest Developments
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Information
13.9.2 Hikma Pharmaceuticals Alprostadil Injection Product Offered
13.9.3 Hikma Pharmaceuticals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hikma Pharmaceuticals Main Business Overview
13.9.5 Hikma Pharmaceuticals Latest Developments
13.10 Lifespan Biotech
13.10.1 Lifespan Biotech Company Information
13.10.2 Lifespan Biotech Alprostadil Injection Product Offered
13.10.3 Lifespan Biotech Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lifespan Biotech Main Business Overview
13.10.5 Lifespan Biotech Latest Developments
13.11 Viatris
13.11.1 Viatris Company Information
13.11.2 Viatris Alprostadil Injection Product Offered
13.11.3 Viatris Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Viatris Main Business Overview
13.11.5 Viatris Latest Developments
13.12 Orifarm Group
13.12.1 Orifarm Group Company Information
13.12.2 Orifarm Group Alprostadil Injection Product Offered
13.12.3 Orifarm Group Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Orifarm Group Main Business Overview
13.12.5 Orifarm Group Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Alprostadil Injection Product Offered
13.13.3 Pfizer Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Alprostadil Injection Product Offered
13.14.3 Sandoz Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Teva Pharmaceutical
13.15.1 Teva Pharmaceutical Company Information
13.15.2 Teva Pharmaceutical Alprostadil Injection Product Offered
13.15.3 Teva Pharmaceutical Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Teva Pharmaceutical Main Business Overview
13.15.5 Teva Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alprostadil Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alprostadil Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alprostadil Injection by Country/Region, 2017, 2022 & 2028
2.2 Alprostadil Injection Segment by Dosage Strength
2.2.1 0.5Mg/Ml
2.2.2 1Mg/Ml
2.2.3 2Mg/Ml
2.2.4 Other
2.3 Alprostadil Injection Sales by Dosage Strength
2.3.1 Global Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Alprostadil Injection Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Alprostadil Injection Sale Price by Dosage Strength (2017-2022)
2.4 Alprostadil Injection Segment by Application
2.4.1 Myocardial Infarction
2.4.2 Thrombotic Vasculitis
2.4.3 Occlusive Arteriosclerosis
2.4.4 Other
2.5 Alprostadil Injection Sales by Application
2.5.1 Global Alprostadil Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Alprostadil Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alprostadil Injection Sale Price by Application (2017-2022)
3 GLOBAL ALPROSTADIL INJECTION BY COMPANY
3.1 Global Alprostadil Injection Breakdown Data by Company
3.1.1 Global Alprostadil Injection Annual Sales by Company (2020-2022)
3.1.2 Global Alprostadil Injection Sales Market Share by Company (2020-2022)
3.2 Global Alprostadil Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Alprostadil Injection Revenue by Company (2020-2022)
3.2.2 Global Alprostadil Injection Revenue Market Share by Company (2020-2022)
3.3 Global Alprostadil Injection Sale Price by Company
3.4 Key Manufacturers Alprostadil Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alprostadil Injection Product Location Distribution
3.4.2 Players Alprostadil Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ALPROSTADIL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Alprostadil Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Alprostadil Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alprostadil Injection Annual Revenue by Geographic Region
4.2 World Historic Alprostadil Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Alprostadil Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alprostadil Injection Annual Revenue by Country/Region
4.3 Americas Alprostadil Injection Sales Growth
4.4 APAC Alprostadil Injection Sales Growth
4.5 Europe Alprostadil Injection Sales Growth
4.6 Middle East & Africa Alprostadil Injection Sales Growth
5 AMERICAS
5.1 Americas Alprostadil Injection Sales by Country
5.1.1 Americas Alprostadil Injection Sales by Country (2017-2022)
5.1.2 Americas Alprostadil Injection Revenue by Country (2017-2022)
5.2 Americas Alprostadil Injection Sales by Dosage Strength
5.3 Americas Alprostadil Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alprostadil Injection Sales by Region
6.1.1 APAC Alprostadil Injection Sales by Region (2017-2022)
6.1.2 APAC Alprostadil Injection Revenue by Region (2017-2022)
6.2 APAC Alprostadil Injection Sales by Dosage Strength
6.3 APAC Alprostadil Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alprostadil Injection by Country
7.1.1 Europe Alprostadil Injection Sales by Country (2017-2022)
7.1.2 Europe Alprostadil Injection Revenue by Country (2017-2022)
7.2 Europe Alprostadil Injection Sales by Dosage Strength
7.3 Europe Alprostadil Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alprostadil Injection by Country
8.1.1 Middle East & Africa Alprostadil Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alprostadil Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Alprostadil Injection Sales by Dosage Strength
8.3 Middle East & Africa Alprostadil Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alprostadil Injection
10.3 Manufacturing Process Analysis of Alprostadil Injection
10.4 Industry Chain Structure of Alprostadil Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alprostadil Injection Distributors
11.3 Alprostadil Injection Customer
12 WORLD FORECAST REVIEW FOR ALPROSTADIL INJECTION BY GEOGRAPHIC REGION
12.1 Global Alprostadil Injection Market Size Forecast by Region
12.1.1 Global Alprostadil Injection Forecast by Region (2023-2028)
12.1.2 Global Alprostadil Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alprostadil Injection Forecast by Dosage Strength
12.7 Global Alprostadil Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Louston
13.1.1 Louston Company Information
13.1.2 Louston Alprostadil Injection Product Offered
13.1.3 Louston Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Louston Main Business Overview
13.1.5 Louston Latest Developments
13.2 CP Group
13.2.1 CP Group Company Information
13.2.2 CP Group Alprostadil Injection Product Offered
13.2.3 CP Group Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CP Group Main Business Overview
13.2.5 CP Group Latest Developments
13.3 Yinglian Biopharmaceutical
13.3.1 Yinglian Biopharmaceutical Company Information
13.3.2 Yinglian Biopharmaceutical Alprostadil Injection Product Offered
13.3.3 Yinglian Biopharmaceutical Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Yinglian Biopharmaceutical Main Business Overview
13.3.5 Yinglian Biopharmaceutical Latest Developments
13.4 Green Biology
13.4.1 Green Biology Company Information
13.4.2 Green Biology Alprostadil Injection Product Offered
13.4.3 Green Biology Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Green Biology Main Business Overview
13.4.5 Green Biology Latest Developments
13.5 HPGC
13.5.1 HPGC Company Information
13.5.2 HPGC Alprostadil Injection Product Offered
13.5.3 HPGC Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 HPGC Main Business Overview
13.5.5 HPGC Latest Developments
13.6 Swiss Parenterals
13.6.1 Swiss Parenterals Company Information
13.6.2 Swiss Parenterals Alprostadil Injection Product Offered
13.6.3 Swiss Parenterals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Swiss Parenterals Main Business Overview
13.6.5 Swiss Parenterals Latest Developments
13.7 Endo Pharm
13.7.1 Endo Pharm Company Information
13.7.2 Endo Pharm Alprostadil Injection Product Offered
13.7.3 Endo Pharm Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Endo Pharm Main Business Overview
13.7.5 Endo Pharm Latest Developments
13.8 Ferring Pharmaceuticals
13.8.1 Ferring Pharmaceuticals Company Information
13.8.2 Ferring Pharmaceuticals Alprostadil Injection Product Offered
13.8.3 Ferring Pharmaceuticals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ferring Pharmaceuticals Main Business Overview
13.8.5 Ferring Pharmaceuticals Latest Developments
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Information
13.9.2 Hikma Pharmaceuticals Alprostadil Injection Product Offered
13.9.3 Hikma Pharmaceuticals Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hikma Pharmaceuticals Main Business Overview
13.9.5 Hikma Pharmaceuticals Latest Developments
13.10 Lifespan Biotech
13.10.1 Lifespan Biotech Company Information
13.10.2 Lifespan Biotech Alprostadil Injection Product Offered
13.10.3 Lifespan Biotech Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Lifespan Biotech Main Business Overview
13.10.5 Lifespan Biotech Latest Developments
13.11 Viatris
13.11.1 Viatris Company Information
13.11.2 Viatris Alprostadil Injection Product Offered
13.11.3 Viatris Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Viatris Main Business Overview
13.11.5 Viatris Latest Developments
13.12 Orifarm Group
13.12.1 Orifarm Group Company Information
13.12.2 Orifarm Group Alprostadil Injection Product Offered
13.12.3 Orifarm Group Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Orifarm Group Main Business Overview
13.12.5 Orifarm Group Latest Developments
13.13 Pfizer
13.13.1 Pfizer Company Information
13.13.2 Pfizer Alprostadil Injection Product Offered
13.13.3 Pfizer Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Pfizer Main Business Overview
13.13.5 Pfizer Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Alprostadil Injection Product Offered
13.14.3 Sandoz Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Teva Pharmaceutical
13.15.1 Teva Pharmaceutical Company Information
13.15.2 Teva Pharmaceutical Alprostadil Injection Product Offered
13.15.3 Teva Pharmaceutical Alprostadil Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Teva Pharmaceutical Main Business Overview
13.15.5 Teva Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alprostadil Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alprostadil Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.5Mg/Ml
Table 4. Major Players of 1Mg/Ml
Table 5. Major Players of 2Mg/Ml
Table 6. Major Players of Other
Table 7. Global Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 8. Global Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 9. Global Alprostadil Injection Revenue by Dosage Strength (2017-2022) & ($ million)
Table 10. Global Alprostadil Injection Revenue Market Share by Dosage Strength (2017-2022)
Table 11. Global Alprostadil Injection Sale Price by Dosage Strength (2017-2022) & (US$/Vial)
Table 12. Global Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 13. Global Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 14. Global Alprostadil Injection Revenue by Application (2017-2022)
Table 15. Global Alprostadil Injection Revenue Market Share by Application (2017-2022)
Table 16. Global Alprostadil Injection Sale Price by Application (2017-2022) & (US$/Vial)
Table 17. Global Alprostadil Injection Sales by Company (2020-2022) & (Vial)
Table 18. Global Alprostadil Injection Sales Market Share by Company (2020-2022)
Table 19. Global Alprostadil Injection Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Alprostadil Injection Revenue Market Share by Company (2020-2022)
Table 21. Global Alprostadil Injection Sale Price by Company (2020-2022) & (US$/Vial)
Table 22. Key Manufacturers Alprostadil Injection Producing Area Distribution and Sales Area
Table 23. Players Alprostadil Injection Products Offered
Table 24. Alprostadil Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Alprostadil Injection Sales by Geographic Region (2017-2022) & (Vial)
Table 28. Global Alprostadil Injection Sales Market Share Geographic Region (2017-2022)
Table 29. Global Alprostadil Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Alprostadil Injection Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Alprostadil Injection Sales by Country/Region (2017-2022) & (Vial)
Table 32. Global Alprostadil Injection Sales Market Share by Country/Region (2017-2022)
Table 33. Global Alprostadil Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Alprostadil Injection Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 36. Americas Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 37. Americas Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 39. Americas Alprostadil Injection Sales by Type (2017-2022) & (Vial)
Table 40. Americas Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 41. Americas Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 42. Americas Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 43. APAC Alprostadil Injection Sales by Region (2017-2022) & (Vial)
Table 44. APAC Alprostadil Injection Sales Market Share by Region (2017-2022)
Table 45. APAC Alprostadil Injection Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Alprostadil Injection Revenue Market Share by Region (2017-2022)
Table 47. APAC Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 48. APAC Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 49. APAC Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 50. APAC Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 51. Europe Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 52. Europe Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 53. Europe Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 55. Europe Alprostadil Injection Sales by Type (2017-2022) & (Vial)
Table 56. Europe Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 57. Europe Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 58. Europe Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 60. Middle East & Africa Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 64. Middle East & Africa Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 65. Middle East & Africa Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 66. Middle East & Africa Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Alprostadil Injection
Table 68. Key Market Challenges & Risks of Alprostadil Injection
Table 69. Key Industry Trends of Alprostadil Injection
Table 70. Alprostadil Injection Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Alprostadil Injection Distributors List
Table 73. Alprostadil Injection Customer List
Table 74. Global Alprostadil Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 75. Global Alprostadil Injection Sales Market Forecast by Region
Table 76. Global Alprostadil Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Alprostadil Injection Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 79. Americas Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Alprostadil Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 81. APAC Alprostadil Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 83. Europe Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 85. Middle East & Africa Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Alprostadil Injection Sales Forecast by Dosage Strength (2023-2028) & (Vial)
Table 87. Global Alprostadil Injection Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 88. Global Alprostadil Injection Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 89. Global Alprostadil Injection Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 90. Global Alprostadil Injection Sales Forecast by Application (2023-2028) & (Vial)
Table 91. Global Alprostadil Injection Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Alprostadil Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Alprostadil Injection Revenue Market Share Forecast by Application (2023-2028)
Table 94. Louston Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Louston Alprostadil Injection Product Offered
Table 96. Louston Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 97. Louston Main Business
Table 98. Louston Latest Developments
Table 99. CP Group Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. CP Group Alprostadil Injection Product Offered
Table 101. CP Group Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 102. CP Group Main Business
Table 103. CP Group Latest Developments
Table 104. Yinglian Biopharmaceutical Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Yinglian Biopharmaceutical Alprostadil Injection Product Offered
Table 106. Yinglian Biopharmaceutical Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 107. Yinglian Biopharmaceutical Main Business
Table 108. Yinglian Biopharmaceutical Latest Developments
Table 109. Green Biology Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Green Biology Alprostadil Injection Product Offered
Table 111. Green Biology Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 112. Green Biology Main Business
Table 113. Green Biology Latest Developments
Table 114. HPGC Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. HPGC Alprostadil Injection Product Offered
Table 116. HPGC Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 117. HPGC Main Business
Table 118. HPGC Latest Developments
Table 119. Swiss Parenterals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Swiss Parenterals Alprostadil Injection Product Offered
Table 121. Swiss Parenterals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 122. Swiss Parenterals Main Business
Table 123. Swiss Parenterals Latest Developments
Table 124. Endo Pharm Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Endo Pharm Alprostadil Injection Product Offered
Table 126. Endo Pharm Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 127. Endo Pharm Main Business
Table 128. Endo Pharm Latest Developments
Table 129. Ferring Pharmaceuticals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Ferring Pharmaceuticals Alprostadil Injection Product Offered
Table 131. Ferring Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 132. Ferring Pharmaceuticals Main Business
Table 133. Ferring Pharmaceuticals Latest Developments
Table 134. Hikma Pharmaceuticals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. Hikma Pharmaceuticals Alprostadil Injection Product Offered
Table 136. Hikma Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 137. Hikma Pharmaceuticals Main Business
Table 138. Hikma Pharmaceuticals Latest Developments
Table 139. Lifespan Biotech Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. Lifespan Biotech Alprostadil Injection Product Offered
Table 141. Lifespan Biotech Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 142. Lifespan Biotech Main Business
Table 143. Lifespan Biotech Latest Developments
Table 144. Viatris Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 145. Viatris Alprostadil Injection Product Offered
Table 146. Viatris Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 147. Viatris Main Business
Table 148. Viatris Latest Developments
Table 149. Orifarm Group Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 150. Orifarm Group Alprostadil Injection Product Offered
Table 151. Orifarm Group Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 152. Orifarm Group Main Business
Table 153. Orifarm Group Latest Developments
Table 154. Pfizer Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 155. Pfizer Alprostadil Injection Product Offered
Table 156. Pfizer Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 157. Pfizer Main Business
Table 158. Pfizer Latest Developments
Table 159. Sandoz Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 160. Sandoz Alprostadil Injection Product Offered
Table 161. Sandoz Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 162. Sandoz Main Business
Table 163. Sandoz Latest Developments
Table 164. Teva Pharmaceutical Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 165. Teva Pharmaceutical Alprostadil Injection Product Offered
Table 166. Teva Pharmaceutical Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 167. Teva Pharmaceutical Main Business
Table 168. Teva Pharmaceutical Latest Developments
Table 1. Alprostadil Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alprostadil Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.5Mg/Ml
Table 4. Major Players of 1Mg/Ml
Table 5. Major Players of 2Mg/Ml
Table 6. Major Players of Other
Table 7. Global Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 8. Global Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 9. Global Alprostadil Injection Revenue by Dosage Strength (2017-2022) & ($ million)
Table 10. Global Alprostadil Injection Revenue Market Share by Dosage Strength (2017-2022)
Table 11. Global Alprostadil Injection Sale Price by Dosage Strength (2017-2022) & (US$/Vial)
Table 12. Global Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 13. Global Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 14. Global Alprostadil Injection Revenue by Application (2017-2022)
Table 15. Global Alprostadil Injection Revenue Market Share by Application (2017-2022)
Table 16. Global Alprostadil Injection Sale Price by Application (2017-2022) & (US$/Vial)
Table 17. Global Alprostadil Injection Sales by Company (2020-2022) & (Vial)
Table 18. Global Alprostadil Injection Sales Market Share by Company (2020-2022)
Table 19. Global Alprostadil Injection Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Alprostadil Injection Revenue Market Share by Company (2020-2022)
Table 21. Global Alprostadil Injection Sale Price by Company (2020-2022) & (US$/Vial)
Table 22. Key Manufacturers Alprostadil Injection Producing Area Distribution and Sales Area
Table 23. Players Alprostadil Injection Products Offered
Table 24. Alprostadil Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Alprostadil Injection Sales by Geographic Region (2017-2022) & (Vial)
Table 28. Global Alprostadil Injection Sales Market Share Geographic Region (2017-2022)
Table 29. Global Alprostadil Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Alprostadil Injection Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Alprostadil Injection Sales by Country/Region (2017-2022) & (Vial)
Table 32. Global Alprostadil Injection Sales Market Share by Country/Region (2017-2022)
Table 33. Global Alprostadil Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Alprostadil Injection Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 36. Americas Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 37. Americas Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 39. Americas Alprostadil Injection Sales by Type (2017-2022) & (Vial)
Table 40. Americas Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 41. Americas Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 42. Americas Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 43. APAC Alprostadil Injection Sales by Region (2017-2022) & (Vial)
Table 44. APAC Alprostadil Injection Sales Market Share by Region (2017-2022)
Table 45. APAC Alprostadil Injection Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Alprostadil Injection Revenue Market Share by Region (2017-2022)
Table 47. APAC Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 48. APAC Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 49. APAC Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 50. APAC Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 51. Europe Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 52. Europe Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 53. Europe Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 55. Europe Alprostadil Injection Sales by Type (2017-2022) & (Vial)
Table 56. Europe Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 57. Europe Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 58. Europe Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Alprostadil Injection Sales by Country (2017-2022) & (Vial)
Table 60. Middle East & Africa Alprostadil Injection Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alprostadil Injection Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Alprostadil Injection Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Alprostadil Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 64. Middle East & Africa Alprostadil Injection Sales Market Share by Dosage Strength (2017-2022)
Table 65. Middle East & Africa Alprostadil Injection Sales by Application (2017-2022) & (Vial)
Table 66. Middle East & Africa Alprostadil Injection Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Alprostadil Injection
Table 68. Key Market Challenges & Risks of Alprostadil Injection
Table 69. Key Industry Trends of Alprostadil Injection
Table 70. Alprostadil Injection Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Alprostadil Injection Distributors List
Table 73. Alprostadil Injection Customer List
Table 74. Global Alprostadil Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 75. Global Alprostadil Injection Sales Market Forecast by Region
Table 76. Global Alprostadil Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Alprostadil Injection Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 79. Americas Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Alprostadil Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 81. APAC Alprostadil Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 83. Europe Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Alprostadil Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 85. Middle East & Africa Alprostadil Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Alprostadil Injection Sales Forecast by Dosage Strength (2023-2028) & (Vial)
Table 87. Global Alprostadil Injection Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 88. Global Alprostadil Injection Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 89. Global Alprostadil Injection Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 90. Global Alprostadil Injection Sales Forecast by Application (2023-2028) & (Vial)
Table 91. Global Alprostadil Injection Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Alprostadil Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Alprostadil Injection Revenue Market Share Forecast by Application (2023-2028)
Table 94. Louston Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Louston Alprostadil Injection Product Offered
Table 96. Louston Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 97. Louston Main Business
Table 98. Louston Latest Developments
Table 99. CP Group Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. CP Group Alprostadil Injection Product Offered
Table 101. CP Group Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 102. CP Group Main Business
Table 103. CP Group Latest Developments
Table 104. Yinglian Biopharmaceutical Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 105. Yinglian Biopharmaceutical Alprostadil Injection Product Offered
Table 106. Yinglian Biopharmaceutical Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 107. Yinglian Biopharmaceutical Main Business
Table 108. Yinglian Biopharmaceutical Latest Developments
Table 109. Green Biology Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Green Biology Alprostadil Injection Product Offered
Table 111. Green Biology Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 112. Green Biology Main Business
Table 113. Green Biology Latest Developments
Table 114. HPGC Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 115. HPGC Alprostadil Injection Product Offered
Table 116. HPGC Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 117. HPGC Main Business
Table 118. HPGC Latest Developments
Table 119. Swiss Parenterals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 120. Swiss Parenterals Alprostadil Injection Product Offered
Table 121. Swiss Parenterals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 122. Swiss Parenterals Main Business
Table 123. Swiss Parenterals Latest Developments
Table 124. Endo Pharm Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 125. Endo Pharm Alprostadil Injection Product Offered
Table 126. Endo Pharm Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 127. Endo Pharm Main Business
Table 128. Endo Pharm Latest Developments
Table 129. Ferring Pharmaceuticals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 130. Ferring Pharmaceuticals Alprostadil Injection Product Offered
Table 131. Ferring Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 132. Ferring Pharmaceuticals Main Business
Table 133. Ferring Pharmaceuticals Latest Developments
Table 134. Hikma Pharmaceuticals Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 135. Hikma Pharmaceuticals Alprostadil Injection Product Offered
Table 136. Hikma Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 137. Hikma Pharmaceuticals Main Business
Table 138. Hikma Pharmaceuticals Latest Developments
Table 139. Lifespan Biotech Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 140. Lifespan Biotech Alprostadil Injection Product Offered
Table 141. Lifespan Biotech Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 142. Lifespan Biotech Main Business
Table 143. Lifespan Biotech Latest Developments
Table 144. Viatris Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 145. Viatris Alprostadil Injection Product Offered
Table 146. Viatris Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 147. Viatris Main Business
Table 148. Viatris Latest Developments
Table 149. Orifarm Group Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 150. Orifarm Group Alprostadil Injection Product Offered
Table 151. Orifarm Group Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 152. Orifarm Group Main Business
Table 153. Orifarm Group Latest Developments
Table 154. Pfizer Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 155. Pfizer Alprostadil Injection Product Offered
Table 156. Pfizer Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 157. Pfizer Main Business
Table 158. Pfizer Latest Developments
Table 159. Sandoz Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 160. Sandoz Alprostadil Injection Product Offered
Table 161. Sandoz Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 162. Sandoz Main Business
Table 163. Sandoz Latest Developments
Table 164. Teva Pharmaceutical Basic Information, Alprostadil Injection Manufacturing Base, Sales Area and Its Competitors
Table 165. Teva Pharmaceutical Alprostadil Injection Product Offered
Table 166. Teva Pharmaceutical Alprostadil Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 167. Teva Pharmaceutical Main Business
Table 168. Teva Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Alprostadil Injection
Figure 2. Alprostadil Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alprostadil Injection Sales Growth Rate 2017-2028 (Vial)
Figure 7. Global Alprostadil Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alprostadil Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.5Mg/Ml
Figure 10. Product Picture of 1Mg/Ml
Figure 11. Product Picture of 2Mg/Ml
Figure 12. Product Picture of Other
Figure 13. Global Alprostadil Injection Sales Market Share by Dosage Strength in 2021
Figure 14. Global Alprostadil Injection Revenue Market Share by Dosage Strength (2017-2022)
Figure 15. Alprostadil Injection Consumed in Myocardial Infarction
Figure 16. Global Alprostadil Injection Market: Myocardial Infarction (2017-2022) & (Vial)
Figure 17. Alprostadil Injection Consumed in Thrombotic Vasculitis
Figure 18. Global Alprostadil Injection Market: Thrombotic Vasculitis (2017-2022) & (Vial)
Figure 19. Alprostadil Injection Consumed in Occlusive Arteriosclerosis
Figure 20. Global Alprostadil Injection Market: Occlusive Arteriosclerosis (2017-2022) & (Vial)
Figure 21. Alprostadil Injection Consumed in Other
Figure 22. Global Alprostadil Injection Market: Other (2017-2022) & (Vial)
Figure 23. Global Alprostadil Injection Sales Market Share by Application (2017-2022)
Figure 24. Global Alprostadil Injection Revenue Market Share by Application in 2021
Figure 25. Alprostadil Injection Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Alprostadil Injection Revenue Market Share by Company in 2021
Figure 27. Global Alprostadil Injection Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Alprostadil Injection Revenue Market Share by Geographic Region in 2021
Figure 29. Global Alprostadil Injection Sales Market Share by Region (2017-2022)
Figure 30. Global Alprostadil Injection Revenue Market Share by Country/Region in 2021
Figure 31. Americas Alprostadil Injection Sales 2017-2022 (Vial)
Figure 32. Americas Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 33. APAC Alprostadil Injection Sales 2017-2022 (Vial)
Figure 34. APAC Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 35. Europe Alprostadil Injection Sales 2017-2022 (Vial)
Figure 36. Europe Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Alprostadil Injection Sales 2017-2022 (Vial)
Figure 38. Middle East & Africa Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 39. Americas Alprostadil Injection Sales Market Share by Country in 2021
Figure 40. Americas Alprostadil Injection Revenue Market Share by Country in 2021
Figure 41. United States Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Alprostadil Injection Sales Market Share by Region in 2021
Figure 46. APAC Alprostadil Injection Revenue Market Share by Regions in 2021
Figure 47. China Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Alprostadil Injection Sales Market Share by Country in 2021
Figure 54. Europe Alprostadil Injection Revenue Market Share by Country in 2021
Figure 55. Germany Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Alprostadil Injection Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Alprostadil Injection Revenue Market Share by Country in 2021
Figure 62. Egypt Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Alprostadil Injection in 2021
Figure 68. Manufacturing Process Analysis of Alprostadil Injection
Figure 69. Industry Chain Structure of Alprostadil Injection
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 1. Picture of Alprostadil Injection
Figure 2. Alprostadil Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alprostadil Injection Sales Growth Rate 2017-2028 (Vial)
Figure 7. Global Alprostadil Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alprostadil Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.5Mg/Ml
Figure 10. Product Picture of 1Mg/Ml
Figure 11. Product Picture of 2Mg/Ml
Figure 12. Product Picture of Other
Figure 13. Global Alprostadil Injection Sales Market Share by Dosage Strength in 2021
Figure 14. Global Alprostadil Injection Revenue Market Share by Dosage Strength (2017-2022)
Figure 15. Alprostadil Injection Consumed in Myocardial Infarction
Figure 16. Global Alprostadil Injection Market: Myocardial Infarction (2017-2022) & (Vial)
Figure 17. Alprostadil Injection Consumed in Thrombotic Vasculitis
Figure 18. Global Alprostadil Injection Market: Thrombotic Vasculitis (2017-2022) & (Vial)
Figure 19. Alprostadil Injection Consumed in Occlusive Arteriosclerosis
Figure 20. Global Alprostadil Injection Market: Occlusive Arteriosclerosis (2017-2022) & (Vial)
Figure 21. Alprostadil Injection Consumed in Other
Figure 22. Global Alprostadil Injection Market: Other (2017-2022) & (Vial)
Figure 23. Global Alprostadil Injection Sales Market Share by Application (2017-2022)
Figure 24. Global Alprostadil Injection Revenue Market Share by Application in 2021
Figure 25. Alprostadil Injection Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Alprostadil Injection Revenue Market Share by Company in 2021
Figure 27. Global Alprostadil Injection Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Alprostadil Injection Revenue Market Share by Geographic Region in 2021
Figure 29. Global Alprostadil Injection Sales Market Share by Region (2017-2022)
Figure 30. Global Alprostadil Injection Revenue Market Share by Country/Region in 2021
Figure 31. Americas Alprostadil Injection Sales 2017-2022 (Vial)
Figure 32. Americas Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 33. APAC Alprostadil Injection Sales 2017-2022 (Vial)
Figure 34. APAC Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 35. Europe Alprostadil Injection Sales 2017-2022 (Vial)
Figure 36. Europe Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Alprostadil Injection Sales 2017-2022 (Vial)
Figure 38. Middle East & Africa Alprostadil Injection Revenue 2017-2022 ($ Millions)
Figure 39. Americas Alprostadil Injection Sales Market Share by Country in 2021
Figure 40. Americas Alprostadil Injection Revenue Market Share by Country in 2021
Figure 41. United States Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Alprostadil Injection Sales Market Share by Region in 2021
Figure 46. APAC Alprostadil Injection Revenue Market Share by Regions in 2021
Figure 47. China Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Alprostadil Injection Sales Market Share by Country in 2021
Figure 54. Europe Alprostadil Injection Revenue Market Share by Country in 2021
Figure 55. Germany Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Alprostadil Injection Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Alprostadil Injection Revenue Market Share by Country in 2021
Figure 62. Egypt Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Alprostadil Injection Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Alprostadil Injection in 2021
Figure 68. Manufacturing Process Analysis of Alprostadil Injection
Figure 69. Industry Chain Structure of Alprostadil Injection
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
